Evidence map›Paper›PMID 32406016›Full record

ArticleAnnals of intensive care2020

Sepsis at ICU admission does not decrease 30-day survival in very old patients: a post-hoc analysis of the VIP1 multinational cohort study.

Mercedes Ibarz, Ariane Boumendil, Lenneke E M Haas, Marian Irazabal, Hans Flaatten, Dylan W de Lange, Alessandro Morandi, Finn H Andersen, Guido Bertolini, Maurizio Cecconi and 17 more

Open access · goldAbstract read
In one paragraph

Article in Annals of intensive care, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Be-SNAP: the Belgian Sepsis National Action Plan.Frontiers in public health · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 18 institutions in 15 countries.

Mercedes IbarzDepartment of Intensive Care Medicine, Hospital Universitario Sagrat Cor, Viladomat 288, 08029, Barcelona, Spain. mibarzvillamayor@gmail.com.ORCID http://orcid.org/0000-0003-2908-0748
Ariane BoumendilAssistance Publique-Hôpital de Paris, Hôpital Saint-Antoine, Service de Réanimation Médicale, 75012, Paris, France.
Lenneke E M HaasDepartment of Intensive Care Medicine, Diakonessenhuis Utrecht, Utrecht, The Netherlands.
Marian IrazabalDepartment of Intensive Care Medicine, Hospital Universitario General de Cataluña, Sant Cugat del Valles, Spain.
Hans FlaattenDepartment of Anaesthesia and Intensive Care, Haukeland University Hospital, Bergen, Norway.
Dylan W de LangeDepartment of Intensive Care Medicine, University Medical Center, University of Utrecht, Utrecht, The Netherlands.
Alessandro MorandiDepartment of Rehabilitation Hospital Ancelle di Cremona, Cremona, Italy.
Finn H AndersenDepartment of Anaesthesia and Intensive Care, Ålesund Hospital, Ålesund, Norway.
Guido BertoliniLaboratorio di Epidemiologia Clinica, Centro di Coordinamento GiViTI Dipartimento di Salute Pubblica, IRCCS - Instituto di Ricerche Farmacologiche "Mario Negri" Ranica, Bergamo, Italy.
Maurizio CecconiDepartment of Anesthesia and Intensive Care Medicine, Humanitas Clinical and Research Center - IRCCS, Via Alessandro 13 Manzoni, 56, 20089, Rozzano, MI, Italy.
Steffen ChristensenDepartment of Anaesthesia and Intensive Care Medicine, Aarhus University Hospital, Aarhus, Denmark.
Loredana FaraldiASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Jesper FjølnerDepartment of Anaesthesia and Intensive Care Medicine, Aarhus University Hospital, Aarhus, Denmark.
Christian JungDepartment of Cardiology, Pulmonology and Angiology, University Hospital, Düsseldorf, Germany.
Brian MarshMater Misericordiae University Hospital, Dublin, Ireland.
Rui MorenoUnidade de Cuidados Intensivos Neurocríticos e Trauma, Hospital de São José, Centro Hospitalar de Lisboa Central, Faculdade de Ciência Médicas de Lisboa, Nova Médical School, Lisbon, Portugal.
Sandra OeyenDepartment of Intensive Care 1K12IC, Ghent University Hospital, Ghent, Belgium.
Christina Agwald ÖhmanKarolinska University Hospital, Stockholm, Sweden.
Bernardo Bollen PintoDepartment of Anaesthesiology, Pharmacology and Intensive Care, Geneva University Hospitals, Geneva, Switzerland.
Ivo W SolimanDepartment of Intensive Care Medicine, University Medical Center, University of Utrecht, Utrecht, The Netherlands.
Wojciech SzczeklikIntensive Care and Perioperative Medicine Division, Jagiellonian University Medical College, Kraków, Poland.
Andreas ValentinKardinal Schwarzenberg Hospital, Schwarzach, Austria.
Ximena WatsonSt George's University Hospital, London, UK.
Tilemachos ZaferidisIntensive Care Unit General Hospital of Larissa, Larissa, Greece.
Bertrand GuidetAssistance Publique-Hôpital de Paris, Hôpital Saint-Antoine, Service de Réanimation Médicale, 75012, Paris, France.
Antonio ArtigasDepartment of Intensive Care Medicine, Hospital Universitario Sagrat Cor, Viladomat 288, 08029, Barcelona, Spain.
VIP1 study
Aarhus University Hospital · DKHaukeland University Hospital · NOHumanitas University · ITJagiellonian University · PLKarolinska University Hospital · SEMater Misericordiae University Hospital · IESorbonne Université · FRUniversitat Autònoma de Barcelona · ESDiakonessenhuis hospital · NLGhent University Hospital · BEGruppo di Ricerca Geriatrica · ITHospital Universitari Sagrat Cor · ESInserm · FRMario Negri Institute for Pharmacological Research · ITNorwegian University of Science and Technology · NOSt George's Hospital · GBUniversity Hospital of Geneva · CHUniversity Hospital of Larissa · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe number of intensive care patients aged ≥ 80 years (Very old Intensive Care Patients; VIPs) is growing. VIPs have high mortality and morbidity and the benefits of ICU admission are frequently questioned. Sepsis incidence has risen in recent years and identification of outcomes is of considerable public importance. We aimed to determine whether VIPs admitted for sepsis had different outcomes than those admitted for other acute reasons and identify potential prognostic factors for 30-day survival.

resultsThis prospective study included VIPs with Sequential Organ Failure Assessment (SOFA) scores ≥ 2 acutely admitted to 307 ICUs in 21 European countries. Of 3869 acutely admitted VIPs, 493 (12.7%) [53.8% male, median age 83 (81-86) years] were admitted for sepsis. Sepsis was defined according to clinical criteria; suspected or demonstrated focus of infection and SOFA score ≥ 2 points. Compared to VIPs admitted for other acute reasons, VIPs admitted for sepsis were younger, had a higher SOFA score (9 vs. 7, p < 0.0001), required more vasoactive drugs [82.2% vs. 55.1%, p < 0.0001] and renal replacement therapies [17.4% vs. 9.9%; p < 0.0001], and had more life-sustaining treatment limitations [37.3% vs. 32.1%; p = 0.02]. Frailty was similar in both groups. Unadjusted 30-day survival was not significantly different between the two groups. After adjustment for age, gender, frailty, and SOFA score, sepsis had no impact on 30-day survival [HR 0.99 (95% CI 0.86-1.15), p = 0.917]. Inverse-probability weight (IPW)-adjusted survival curves for the first 30 days after ICU admission were similar for acute septic and non-septic patients [HR: 1.00 (95% CI 0.87-1.17), p = 0.95]. A matched-pair analysis in which patients with sepsis were matched with two control patients of the same gender with the same age, SOFA score, and level of frailty was also performed. A Cox proportional hazard regression model stratified on the matched pairs showed that 30-day survival was similar in both groups [57.2% (95% CI 52.7-60.7) vs. 57.1% (95% CI 53.7-60.1), p = 0.85].

conclusionsAfter adjusting for organ dysfunction, sepsis at admission was not independently associated with decreased 30-day survival in this multinational study of 3869 VIPs. Age, frailty, and SOFA score were independently associated with survival.

Indexed as

Intensive careMortalityOutcomeSepsisSeverity of illnessSurvivalVery old

Identifiers

PMID32406016
PMCPMC7221097
OpenAlexW3025816606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.